Unilever plc SEC filings document the disclosure record of a foreign private issuer with ordinary shares and American depositary shares tied to a global consumer goods business. Form 6-K reports include voting-rights and capital updates, share buyback announcements, Annual General Meeting notices, proxy materials and public disclosures of transactions by persons discharging managerial responsibilities.
The filing record also incorporates operating and financial results, material-event reports, registration-statement references, risk disclosures and governance matters. These documents describe Unilever's capital structure, shareholder voting mechanics, board authorities, equity compensation registrations and recurring regulatory communications under U.S. and U.K. disclosure regimes.
Unilever PLC reported dividend-reinvestment transactions in its ordinary shares by nine people with the following roles on September 23, 2026: Chief Financial Officer Srinivas Phatak; Business Group President, Home Care Eduardo Campanella; President 1 Unilever Markets Reginaldo Ecclissato; CEO & Managing Director of Hindustan Unilever Limited Priya Nair; Chief People Officer Mairéad Nayager; Business Group President, Foods Heiko Schipper; Chief Research & Development Officer Richard Slater; Chief Supply Chain and Operations Officer Willem Uijen; and Chief Legal Officer and Group Company Secretary Prakash Kakkad. The reported prices were £47.14262 per share for GBP-denominated shares traded on London Stock Exchange and €54.8102 per share for EUR-denominated shares traded on Euronext Amsterdam. The notices state that the agreements were entered into during an open period.
Unilever PLC disclosed that Heiko Schipper, Business Group President, Foods and a member of the Unilever Leadership Executive, sold 345 ordinary 3 1/2 pence shares on September 23, 2026. The reported price was €54.79 per share, with an aggregate value of €18,902.55; the transaction took place on Euronext Amsterdam.
UNILEVER PLC (UL), through its planned separation and combination of Unilever Foods with McCormick, is part of a transaction intended to create a pure-play global flavor company with approximately $20 billion in combined sales. McCormick’s management outlined how the combined business is expected to benefit from expanded global brands, broader geographic reach and a strengthened foodservice platform.
The plan targets $600 million of net cost synergies, with about two-thirds expected by year two after closing, mainly from SG&A and procurement savings. Emerging markets are expected to contribute over 40% of revenue post-close, and the combined company is modeled for 3%–5% sales growth and higher adjusted operating margins by year three. McCormick also highlighted expected strong free cash flow, with $1.5–$2.0 billion earmarked for debt reduction by year two and an intention to maintain its dividend track record, while the parties continue to pursue regulatory approvals and a targeted mid‑2027 closing.
UNILEVER PLC (UL) reports an update on its voting rights and capital. As at 31 August 2026, the company had 2,185,205,247 issued ordinary shares of 3 1/2p each. Of these, 30,703,780 were held as treasury shares and 173,846 were held by or on behalf of Unilever group companies, whose voting rights are not exercisable.
As a result, there were 2,154,327,621 Unilever PLC shares with voting rights on that date. This figure may be used by shareholders as the denominator when determining whether they must notify their interest in UL under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
UNILEVER PLC (UL) reported a management share transaction by Fabian Garcia, Business Group President, Personal Care and member of the Unilever Leadership Executive. Garcia sold 15,643 American Depositary Receipts (ADRs), each representing one Unilever PLC ordinary 3 1/2 pence share, at $63.915 per ADR on 21 August 2026 on the New York Stock Exchange, for an aggregate value of $999,822.35.
UNILEVER PLC (UL) received a notice that Fabian Garcia intends to sell up to 15,643 American Depositary Shares of the company under Rule 144 through Fidelity Brokerage Services LLC. The approximate aggregate market value of the planned sale is $999,822.35, with an approximate sale date of 08/21/2026 on the NYSE. These securities are reported as having been acquired from the issuer via restricted stock vesting dated 02/12/2026. The filing also states that 2,181,005,247 American Depositary Shares were outstanding for this class.
Unilever PLC provides an update on its share capital and voting rights in line with UK Financial Conduct Authority disclosure rules. As at 31 July 2026, issued share capital consisted of 2,185,205,247 ordinary shares of 3 1/2p each.
Of these, 30,703,780 were held as treasury shares and 174,123 were Unilever Group Shares, whose voting rights are not exercisable. This results in 2,154,327,344 shares with voting rights, which shareholders may use as the denominator for UK transparency notifications.
Unilever PLC reported a transaction by senior manager Heiko Schipper, Business Group President, Foods. He sold 1,400 ordinary shares on 31 July 2026 at €55.82 per share on Euronext Amsterdam, for a total value of €78,148, under PDMR disclosure rules.
Unilever PLC reported solid volume-led growth for the first half of 2026, with underlying sales growth of 4.8% driven by 4.2% volume and 0.6% price. Turnover was €25.6 billion, up 0.5% as operational gains and acquisitions offset a (4.9)% currency drag. All four Business Groups delivered volume-led growth; Home Care grew 7.6% USG and Beauty & Wellbeing 5.9%.
Underlying operating profit reached €5.2 billion, with underlying operating margin at 20.3%, up 10bps, while diluted EPS from continuing operations declined 2.5% to €1.38 and underlying EPS rose 2.4% to €1.61. Free cash flow improved to €1.5 billion. Net debt increased to €26.0 billion, or 2.3x net debt/UEBITDA, mainly after a completed €1.5 billion share buyback and dividends. The company reaffirmed capital-return priorities, declared a quarterly dividend of €0.4664 per share, and continues to progress the planned combination of its Foods business with McCormick, targeting completion by mid‑2027. Guidance for 2026 calls for USG of 4–6% with around 3% volume and a modest improvement in underlying operating margin versus 20.0% in 2025.